Bradley M. Pitman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bradley M. Pitman has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Prashanthan Sanders
Centre for Heart Rhythm Disorders, Adelaide University and Royal Adelaide Hospital, Adelaide, Australia
6 shared publications - Christopher X. Wong
Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia
4 shared publications - Dennis H. Lau
Australian Dysautonomia and Arrhythmia Research Collaborative, The University of Adelaide, Adelaide, SA, Australia; South Australian Health and Medical Research Institute, Adelaide, SA, Australia; Department of Cardiology, Royal Adelaide Hospital, Adelaide, SA, Australia
4 shared publications - Amenah Jaghoori
Univ Adelaide, Ctr Heart Rhythm Disorders, 1 Port Rd, Adelaide, SA 5000, Australia
2 shared publications - Andrew Chew
Flinders Univ S Australia, Adelaide, SA, Australia
2 shared publications - Benedict T. Costello
Baker IDI Heart & Diabetes Institute and Alfred Hospital, Melbourne, Vic, Australia
2 shared publications
Latest Publications
- Open Access
- 23 June 2025
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (3)
Pulmonary vein isolation does not alter cardiovascular afferent autonomic reflexes in atrial fibrillation
Background: Pulmonary vein isolation (PVI) remains the cornerstone of atrial fibrillation (AF) ablation. We previously demonstrated abnormal cardiac volume‐sensitive reflexes (whose receptors are co‐located in veno‐atrial tissue) in AF patients. Whether PVI disrupts afferent nerves is unknown.Objectives: Evaluate whether PVI disrupts afferent volume‐sensitive reflexes.Methods: We consecutively studied autonomic reflexes in AF patients undergoing PVI, repeating the study post‐PVI, if AF‐free >6 months. We excluded patients with AF recurrence/procedural complications, allowing repeat procedures. We measured beat‐to‐beat mean arterial pressure (MAP) and heart rate (HR) continuously during low‐level Lower Body Negative Pressure (LBNP), at 0, −20 and −40 mmHg (predominantly testing volume baroreceptors); Valsalva reflex (predominantly arterial baroreceptors); and Isometric Handgrip reflex (IHR, both). LBNP produces reflex vasoconstriction, evaluated from forearm blood flow (FBF ∝ 1/vascular resistance).Results: 18 patients were studied pre‐PVI; n = 9 completed both visits. Mean age was 64 ± 3 years (78% male); BMI 28 ± 1 kg/m2; LA size 37 ± 2 mL/m2; and left ventricular function 65 ± 3%. Despite alterations in heart rate variability (HRV), there was no difference in IHR, Valsalva, or LBNP responses pre‐ versus post‐PVI. During LBNP, MAP decreased slightly both pre‐ (−1.6 ± 3%) and post‐PVI (−2.8 ± 1.8%); p = .7. HR increased similarly (p = .7) pre‐ (10.6 ± 6.4%) and post‐PVI (7.2 ± 1.5%). FBF response was unchanged (p = .8). Resting (arterial) baroreflex sensitivity was unaltered.Conclusion: PVI does not impair cardiovascular reflexes involving afferent baroreceptors, suggesting HRV changes reflect efferent modulation or ablation adequacy rather than afferent disruption. Whether disrupting sino‐atrial efferent nerves represents a marker of adequate ablation or influences PVI outcomes requires evaluation.
- 23 June 2025
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (3)
Open AccessPulmonary vein isolation does not alter cardiovascular afferent autonomic reflexes in atrial fibrillation
Background: Pulmonary vein isolation (PVI) remains the cornerstone of atrial fibrillation (AF) ablation. We previously demonstrated abnormal cardiac volume‐sensitive reflexes (whose receptors are co‐located in veno‐atrial tissue) in AF patients. Whether PVI disrupts afferent nerves is unknown.Objectives: Evaluate whether PVI disrupts afferent volume‐sensitive reflexes.Methods: We consecutively studied autonomic reflexes in AF patients undergoing PVI, repeating the study post‐PVI, if AF‐free >6 months. We excluded patients with AF recurrence/procedural complications, allowing repeat procedures. We measured beat‐to‐beat mean arterial pressure (MAP) and heart rate (HR) continuously during low‐level Lower Body Negative Pressure (LBNP), at 0, −20 and −40 mmHg (predominantly testing volume baroreceptors); Valsalva reflex (predominantly arterial baroreceptors); and Isometric Handgrip reflex (IHR, both). LBNP produces reflex vasoconstriction, evaluated from forearm blood flow (FBF ∝ 1/vascular resistance).Results: 18 patients were studied pre‐PVI; n = 9 completed both visits. Mean age was 64 ± 3 years (78% male); BMI 28 ± 1 kg/m2; LA size 37 ± 2 mL/m2; and left ventricular function 65 ± 3%. Despite alterations in heart rate variability (HRV), there was no difference in IHR, Valsalva, or LBNP responses pre‐ versus post‐PVI. During LBNP, MAP decreased slightly both pre‐ (−1.6 ± 3%) and post‐PVI (−2.8 ± 1.8%); p = .7. HR increased similarly (p = .7) pre‐ (10.6 ± 6.4%) and post‐PVI (7.2 ± 1.5%). FBF response was unchanged (p = .8). Resting (arterial) baroreflex sensitivity was unaltered.Conclusion: PVI does not impair cardiovascular reflexes involving afferent baroreceptors, suggesting HRV changes reflect efferent modulation or ablation adequacy rather than afferent disruption. Whether disrupting sino‐atrial efferent nerves represents a marker of adequate ablation or influences PVI outcomes requires evaluation.
- 18 May 2023
- Published by Elsevier in Heart Rhythm
- Vol. 20 (5) , S333
PO-02-039 THE EFFECT OF PULSED-FIELD ABLATION FIELD STRENGTH AND NUMBER OF APPLICATIONS IN ACUTE PULMONARY VEIN ISOLATION: A PRECLINICAL STUDY
- 18 May 2023
- Published by Elsevier in Heart Rhythm
- Vol. 20 (5) , S333
PO-02-039 THE EFFECT OF PULSED-FIELD ABLATION FIELD STRENGTH AND NUMBER OF APPLICATIONS IN ACUTE PULMONARY VEIN ISOLATION: A PRECLINICAL STUDY
- 26 November 2022
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 32 (2) , 252-260
The Burden of Cardiac Implantable Electronic Device Checks in the Peri-MRI Setting: The CHECK-MRI Study
- 26 November 2022
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 32 (2) , 252-260
The Burden of Cardiac Implantable Electronic Device Checks in the Peri-MRI Setting: The CHECK-MRI Study
- 10 February 2022
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 31 (4) , 457-459
Tailored Cryoballoon Pulmonary Vein Ablation for Atrial Fibrillation: When to Stop the Freeze?
- 10 February 2022
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 31 (4) , 457-459
Tailored Cryoballoon Pulmonary Vein Ablation for Atrial Fibrillation: When to Stop the Freeze?
- Open Access
- 1 June 2021
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 34, 100775
Left atrial, pulmonary vein, and left atrial appendage anatomy in Indigenous individuals: Implications for atrial fibrillation
- 1 June 2021
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 34, 100775
Open AccessLeft atrial, pulmonary vein, and left atrial appendage anatomy in Indigenous individuals: Implications for atrial fibrillation
- Open Access
- 19 May 2021
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 9 (5) , e24470
Performance of a Mobile Single-Lead Electrocardiogram Technology for Atrial Fibrillation Screening in a Semirural African Population: Insights From “The Heart of Ethiopia: Focus on Atrial Fibrillation” (TEFF-AF) Study
Background: Atrial fibrillation (AF) screening using mobile single-lead electrocardiogram (ECG) devices has demonstrated variable sensitivity and specificity. However, limited data exists on the use of such devices in low-resource countries. Objective: The goal of the research was to evaluate the utility of the KardiaMobile device’s (AliveCor Inc) automated algorithm for AF screening in a semirural Ethiopian population. Methods: Analysis was performed on 30-second single-lead ECG tracings obtained using the KardiaMobile device from 1500 TEFF-AF (The Heart of Ethiopia: Focus on Atrial Fibrillation) study participants. We evaluated the performance of the KardiaMobile automated algorithm against cardiologists’ interpretations of 30-second single-lead ECG for AF screening. Results: A total of 1709 single-lead ECG tracings (including repeat tracing on 209 occasions) were analyzed from 1500 Ethiopians (63.53% [953/1500] male, mean age 35 [SD 13] years) who presented for AF screening. Initial successful rhythm decision (normal or possible AF) with one single-lead ECG tracing was lower with the KardiaMobile automated algorithm versus manual verification by cardiologists (1176/1500, 78.40%, vs 1455/1500, 97.00%; P<.001). Repeat single-lead ECG tracings in 209 individuals improved overall rhythm decision, but the KardiaMobile automated algorithm remained inferior (1301/1500, 86.73%, vs 1479/1500, 98.60%; P<.001). The key reasons underlying unsuccessful KardiaMobile automated rhythm determination include poor quality/noisy tracings (214/408, 52.45%), frequent ectopy (22/408, 5.39%), and tachycardia (>100 bpm; 167/408, 40.93%). The sensitivity and specificity of rhythm decision using KardiaMobile automated algorithm were 80.27% (1168/1455) and 82.22% (37/45), respectively. Conclusions: The performance of the KardiaMobile automated algorithm was suboptimal when used for AF screening. However, the KardiaMobile single-lead ECG device remains an excellent AF screening tool with appropriate clinician input and repeat tracing. Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN12619001107112; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=378057&isReview=true
- 19 May 2021
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 9 (5) , e24470
Open AccessPerformance of a Mobile Single-Lead Electrocardiogram Technology for Atrial Fibrillation Screening in a Semirural African Population: Insights From “The Heart of Ethiopia: Focus on Atrial Fibrillation” (TEFF-AF) Study
Background: Atrial fibrillation (AF) screening using mobile single-lead electrocardiogram (ECG) devices has demonstrated variable sensitivity and specificity. However, limited data exists on the use of such devices in low-resource countries. Objective: The goal of the research was to evaluate the utility of the KardiaMobile device’s (AliveCor Inc) automated algorithm for AF screening in a semirural Ethiopian population. Methods: Analysis was performed on 30-second single-lead ECG tracings obtained using the KardiaMobile device from 1500 TEFF-AF (The Heart of Ethiopia: Focus on Atrial Fibrillation) study participants. We evaluated the performance of the KardiaMobile automated algorithm against cardiologists’ interpretations of 30-second single-lead ECG for AF screening. Results: A total of 1709 single-lead ECG tracings (including repeat tracing on 209 occasions) were analyzed from 1500 Ethiopians (63.53% [953/1500] male, mean age 35 [SD 13] years) who presented for AF screening. Initial successful rhythm decision (normal or possible AF) with one single-lead ECG tracing was lower with the KardiaMobile automated algorithm versus manual verification by cardiologists (1176/1500, 78.40%, vs 1455/1500, 97.00%; P<.001). Repeat single-lead ECG tracings in 209 individuals improved overall rhythm decision, but the KardiaMobile automated algorithm remained inferior (1301/1500, 86.73%, vs 1479/1500, 98.60%; P<.001). The key reasons underlying unsuccessful KardiaMobile automated rhythm determination include poor quality/noisy tracings (214/408, 52.45%), frequent ectopy (22/408, 5.39%), and tachycardia (>100 bpm; 167/408, 40.93%). The sensitivity and specificity of rhythm decision using KardiaMobile automated algorithm were 80.27% (1168/1455) and 82.22% (37/45), respectively. Conclusions: The performance of the KardiaMobile automated algorithm was suboptimal when used for AF screening. However, the KardiaMobile single-lead ECG device remains an excellent AF screening tool with appropriate clinician input and repeat tracing. Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN12619001107112; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=378057&isReview=true
- 1 December 2020
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 29 (12) , 1808-1814
Clinical Utility of Stress Echocardiography in Remote Indigenous and Non-Indigenous Populations: A 10-Year Study in Central Australia
- 1 December 2020
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 29 (12) , 1808-1814
Clinical Utility of Stress Echocardiography in Remote Indigenous and Non-Indigenous Populations: A 10-Year Study in Central Australia
- Open Access
- 8 November 2020
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 29, S351-S352
701 Left Atrial, Pulmonary Vein, and Left Atrial Appendage Anatomy in Indigenous Individuals: Implications for Atrial Fibrillation
- 8 November 2020
- Published by Elsevier in Heart, Lung and Circulation
- Vol. 29, S351-S352
Open Access701 Left Atrial, Pulmonary Vein, and Left Atrial Appendage Anatomy in Indigenous Individuals: Implications for Atrial Fibrillation
- Open Access
- 21 September 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Performance of a Mobile Single-Lead Electrocardiogram Technology for Atrial Fibrillation Screening in a Semirural African Population: Insights From “The Heart of Ethiopia: Focus on Atrial Fibrillation” (TEFF-AF) Study (Preprint)
BACKGROUND Atrial fibrillation (AF) screening using mobile single-lead electrocardiogram (ECG) devices has demonstrated variable sensitivity and specificity. However, limited data exists on the use of such devices in low-resource countries. OBJECTIVE The goal of the research was to evaluate the utility of the KardiaMobile device’s (AliveCor Inc) automated algorithm for AF screening in a semirural Ethiopian population. METHODS Analysis was performed on 30-second single-lead ECG tracings obtained using the KardiaMobile device from 1500 TEFF-AF (The Heart of Ethiopia: Focus on Atrial Fibrillation) study participants. We evaluated the performance of the KardiaMobile automated algorithm against cardiologists’ interpretations of 30-second single-lead ECG for AF screening. RESULTS A total of 1709 single-lead ECG tracings (including repeat tracing on 209 occasions) were analyzed from 1500 Ethiopians (63.53% [953/1500] male, mean age 35 [SD 13] years) who presented for AF screening. Initial successful rhythm decision (normal or possible AF) with one single-lead ECG tracing was lower with the KardiaMobile automated algorithm versus manual verification by cardiologists (1176/1500, 78.40%, vs 1455/1500, 97.00%; P<.001). Repeat single-lead ECG tracings in 209 individuals improved overall rhythm decision, but the KardiaMobile automated algorithm remained inferior (1301/1500, 86.73%, vs 1479/1500, 98.60%; P<.001). The key reasons underlying unsuccessful KardiaMobile automated rhythm determination include poor quality/noisy tracings (214/408, 52.45%), frequent ectopy (22/408, 5.39%), and tachycardia (>100 bpm; 167/408, 40.93%). The sensitivity and specificity of rhythm decision using KardiaMobile automated algorithm were 80.27% (1168/1455) and 82.22% (37/45), respectively. CONCLUSIONS The performance of the KardiaMobile automated algorithm was suboptimal when used for AF screening. However, the KardiaMobile single-lead ECG device remains an excellent AF screening tool with appropriate clinician input and repeat tracing. CLINICALTRIAL Australian New Zealand Clinical Trials Registry ACTRN12619001107112; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=378057&isReview=true
- 21 September 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPerformance of a Mobile Single-Lead Electrocardiogram Technology for Atrial Fibrillation Screening in a Semirural African Population: Insights From “The Heart of Ethiopia: Focus on Atrial Fibrillation” (TEFF-AF) Study (Preprint)
BACKGROUND Atrial fibrillation (AF) screening using mobile single-lead electrocardiogram (ECG) devices has demonstrated variable sensitivity and specificity. However, limited data exists on the use of such devices in low-resource countries. OBJECTIVE The goal of the research was to evaluate the utility of the KardiaMobile device’s (AliveCor Inc) automated algorithm for AF screening in a semirural Ethiopian population. METHODS Analysis was performed on 30-second single-lead ECG tracings obtained using the KardiaMobile device from 1500 TEFF-AF (The Heart of Ethiopia: Focus on Atrial Fibrillation) study participants. We evaluated the performance of the KardiaMobile automated algorithm against cardiologists’ interpretations of 30-second single-lead ECG for AF screening. RESULTS A total of 1709 single-lead ECG tracings (including repeat tracing on 209 occasions) were analyzed from 1500 Ethiopians (63.53% [953/1500] male, mean age 35 [SD 13] years) who presented for AF screening. Initial successful rhythm decision (normal or possible AF) with one single-lead ECG tracing was lower with the KardiaMobile automated algorithm versus manual verification by cardiologists (1176/1500, 78.40%, vs 1455/1500, 97.00%; P<.001). Repeat single-lead ECG tracings in 209 individuals improved overall rhythm decision, but the KardiaMobile automated algorithm remained inferior (1301/1500, 86.73%, vs 1479/1500, 98.60%; P<.001). The key reasons underlying unsuccessful KardiaMobile automated rhythm determination include poor quality/noisy tracings (214/408, 52.45%), frequent ectopy (22/408, 5.39%), and tachycardia (>100 bpm; 167/408, 40.93%). The sensitivity and specificity of rhythm decision using KardiaMobile automated algorithm were 80.27% (1168/1455) and 82.22% (37/45), respectively. CONCLUSIONS The performance of the KardiaMobile automated algorithm was suboptimal when used for AF screening. However, the KardiaMobile single-lead ECG device remains an excellent AF screening tool with appropriate clinician input and repeat tracing. CLINICALTRIAL Australian New Zealand Clinical Trials Registry ACTRN12619001107112; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=378057&isReview=true